Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Prospective Cohort Study Assessing the Use of Weight-Adjusted Low-Molecular-Weight-Heparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism

NCT03297359 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT03297359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03297359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Prospective Cohort Study Assessing the Use of Weight-Adjusted Low-Molecular-Weight-Heparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 2
Overall status
Terminated
Start date
March 21, 2018
Completion date
November 30, 2023
Enrollment
92 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, obesity, venous thromboembolism